0001209191-17-003674.txt : 20170113
0001209191-17-003674.hdr.sgml : 20170113
20170113163316
ACCESSION NUMBER: 0001209191-17-003674
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170111
FILED AS OF DATE: 20170113
DATE AS OF CHANGE: 20170113
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ADURO BIOTECH, INC.
CENTRAL INDEX KEY: 0001435049
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 740 HEINZ AVENUE
CITY: BERKELEY
STATE: CA
ZIP: 94710
BUSINESS PHONE: 510-848-4400
MAIL ADDRESS:
STREET 1: 740 HEINZ AVENUE
CITY: BERKELEY
STATE: CA
ZIP: 94710
FORMER COMPANY:
FORMER CONFORMED NAME: ADURO BIOTECH
DATE OF NAME CHANGE: 20080514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Templeman Blaine
CENTRAL INDEX KEY: 0001653641
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37345
FILM NUMBER: 17528216
MAIL ADDRESS:
STREET 1: C/O ADURO BIOTECH, INC.
STREET 2: 740 HEINZ AVENUE
CITY: BERKELEY
STATE: CA
ZIP: 94710
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-01-11
0
0001435049
ADURO BIOTECH, INC.
ADRO
0001653641
Templeman Blaine
C/O ADURO BIOTECH, INC.
740 HEINZ AVENUE
BERKELEY
CA
94710
0
1
0
0
Executive VP, General Counsel
Common Stock
2017-01-11
4
S
0
3785
11.95
D
37300
D
The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2016.
Includes 1,621 shares and 584 shares acquired by the Reporting Person under the Issuer stock purchase plan on May 13, 2016 and November 15, 2016, respectively.
/s/ Jennifer Lew, Attorney-in-Fact
2017-01-13